Abstract:The main cause of cancer-related fatalities is cancer metastasis to other body parts, and increased glycolysis is crucial for cancer cells to maintain their elevated levels of growth and energy requirements, ultimately facilitating the invasion and spread of tumors. The Warburg effect plays a significant role in the advancement of cancer, and focusing on the suppression of aerobic glycolysis could offer a promising strategy for anti-cancer treatment. Various glycolysis processes are associated with tumor metastasis, primarily involving non-coding RNA (ncRNAs), signaling pathways, transcription factors, and more. Various categories of noncoding RNAs, including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), have shown promise in influencing glucose metabolism associated with the spread of tumors. Additionally, circular RNAs (circRNAs) and long non-coding RNAs (lncRNAs) predominantly act as competitive endogenous RNAs (ceRNAs) by sequestering microRNAs, thereby modulating the expression of target genes and exerting significant influence on the metabolic processes of cancerous cells. Furthermore, the process of tumor metastasis through glycolysis also encompasses various signaling pathways (such as PI3K/AKT, HIF, Wnt/β- Catenin, and ERK, among others) and transcription factors. This article delineates the primary mechanisms through which non-coding RNAs, signaling pathways, and transcription factors contribute to glycolysis in tumor metastasis. It also investigates the potential use of these factors as prognostic markers and targets for cancer treatment. The manuscript also explores the innovative applications of specific traditional Chinese medicine and clinical Western medications in inhibiting tumor spread through glycolysis mechanisms, offering potential as new candidates for anti-cancer drugs.

Reciprocal Dynamics of Metabolism and mRNA Translation in Tumor Angiogenesis

Metabolism and mRNA translation: a nexus of cancer plasticity

Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy

Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights

Targeting Angiogenic Metabolism in Disease

Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies

Metabolic reprogramming and interventions in angiogenesis

Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis

Targeting amino acid metabolism for cancer therapy

The crosstalk between metabolism and translation

The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment

Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed.

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy.

Recent Advances in the Glycolytic Processes Linked to Tumor Metastasis

Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors

Metabolic rewiring and communication in cancer immunity

Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism

Tumor Energy Metabolism: Implications for Therapeutic Targets

Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment